ArticleAntimicrobial agents and chemotherapy2020

Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii.

Moti Chapagain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.